关于公司
- 法定名称: Viwit Pharmaceutical Co., Ltd.
- 国际名称: 维威制药 (Viwit Pharmaceutical Co., Ltd.), China
- 品牌 / 商号: Viwit
- 注册国家: China
描述:
Viwit Pharmaceutical Co., Ltd., established in 2006, manufactures pharmaceutical intermediates and active pharmaceutical ingredients with a particular specialization in borane- and boron-based reducing reagents, including borane-dimethyl sulfide, borane-THF, borane-pyridine, and various borane-amine complexes, alongside chiral pyrrolidine, piperidine, and indanyl building blocks. Its finished API portfolio includes aprepitant and fosaprepitant dimeglumine, varenicline tartrate, luliconazole, vildagliptin, and the MRI contrast agents gadobutrol monohydrate and gadolinium meglumine. The company offers CRO, CMO, and CDMO contract manufacturing under OEM, ODM, and own-brand arrangements, and sells across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
业务活动
膳食补充剂与营养保健品
供应商
成品制剂
制造商
生物制药产品
生物技术/生物制药公司
原料药 (API)
制造商
医药化学品
制造商
ATC(解剖学-治疗学-化学)分类系统
制造商
销售市场
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
主要产品/服务
- 原料药 (API): Gadobutrol monohydrate, Aprepitant, Lifitegrast, Varenicline Tartrate, EFINACONAZOLE, Fosaprepitant dimeglumine, Gadolinium meglumine, Luliconazole, Miraberon
- 合同与外包服务: Product Development
- 成品制剂: Finished antibiotic medicines
- 医药化学品: (+)-B-Chlorodiisopinocampheylborane, Catecholborane, (R)-(+)-2-(Diphenylhydroxymethyl)pyrrolidine, (S)-(-)-2-(Diphenylhydroxymethyl)pyrrolidine, Borane tetrahydrofuran complex, (R)-(5-Cyano-2, 3-dihydro-1H-inden-1-yl) carbamic acid tert-butyl ester, (R)-tert-Butyl (5-bromo-2, 3-dihydro-1H-inden-1-yl) carbamate(R)-TERT-BUTYL (5-BROMO-2,3-DIHYDRO-1H-INDEN-1-YL)CARBAMATE, (R)-1-Amino -2, 3-dihydro-1H-indene-5-carbonitrile hydrochloride, 1-Methyl-6-boronic acid pinacolyl ester-3,4-dihydroquinoline -2(1H)-one, (1S,2S,3R,5S)-(+)-2,3-Pinanediol, 1-(2-Tetrahydropyranyl)-1H-pyrazole-5-boronic acid ester, 1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methylepoxyethyl-2-yl) methyl)-1H-1,2,4-triazole, 1-BOC-3, 3-Dimethyl-4-oxopiperidine, 1-HYDROXYETHYL ADAMANTANE, [1,1 '-Biphenyl]-4-yl [4-[[1,1'-biphenyl]-4-sulfanyl] phenyl] thioninium-tetrakis (pentafluorophenyl) borate, 1,1-Dimethylethyl 4-hydroxy-4-[(2-methoxyethoxy)methyl]-1-piperidinecarboxylate, 1,2-Bis [(trifluorovinyl) oxy] ethane, 1H-indazole -7-carboxylic acid methyl ester, 1H-indazole-7-carboxamide, (1R,2R,3S,5R)-(-)-2,3-Pinanediol, 2 - methyl -5-- nitroimidazole, 2 '-fluoro -1,1': 4 ', 1'-terphenyl, 2-((1R)-1-AMINOETHYL)-4-FLUOROPHENOL, 2-(2-Amino-5-bromo-benzoyl) pyridine, 2-Chloro-1, 3,2-dioxaphosphine, 2-Chloro-3-fluorophenylboronic acid, 2-Fluoro-6-hydroxyphenylboronic acid pinacol ester, ((2-Fluoro-8-(4,4, 5,5-tetramethyl -1,3, 2-dioxaborolan-2-yl) naphthalen-1-yl) ethynyl) triisopropylsilane, 2-Methylpyridine-N-borane, (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1, 2,4-triazol-1-yl) butane-2, 3-diol, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-morpholine hydrochloride(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl) morpholine p-benzenesulfonate, (3-(9-borabicyclo[3.3.1]nonan-9-yl)propyl)triphenylphosphoniumebromide, 3-acetamidopyrazole, 3-Chloro-5-hydroxybenzonitrile, 3-Fluoro-5-hydroxybenzonitrile, 3-fluoroquinoline -5-borate pinacol ester, 3,5-Difluorobenzonitrile, 4-Bromo-2-fluorobiphenyl, 4-Cyano -1-(2,6-difluorobenzyl)-1H-1,2,3-triazole, 4-Methanesulfonyl-cyclohexyl ketone, 4-Methylene Piperidine Hydrochloride, 5-Bromo-3-fluoroquinoline, 5-chloromethyl-2, 4-dihydro [1,2,4] triazol-3-one, 5-ethyl -2-methyl pyridine borane, 6-Bromo-3-iodo-1-methyl-1H-indazole, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane-2, 4-dione, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane, 7-Carboxyl -1H-indazole, 7-Hydroxy-[1,2,4] triazolo [1,5-A] pyridine, 9-Borabicyclo[3.3.1]nonane, Borane-2-picoline complex, Borane-ammonia, borane diethylamine complex, Borane-dimethyl sulfide complex intermediates, Borane-dimethylamine, Borane-N,N-diisopropylethylamine, Borane-pyridine, Borane-tert-butylamine complex, borane triethylamine complex, borane trimethylamine complex, cis-1-BOC-3, 4-dihydroxypyrrolidine, Cis-1-BOC-3-hydroxy-4-methoxypyrrolidine, cis-1-BOC-pyrrolidine-3, 4-diamine, cis-3, 4-dihydroxypyrrolidine hydrochloride, Decafluoro-3-methoxy-2-trifluoromethylpentane, Diethyl (3-Pyridyl) Borane, DOTA intermediates, ethyl 2-acetyl acetate chloride, Ethyl 3-(2-chlorophenoxy)-2-butenoate, FOMC-Glutamic acid -5-methyl ester, Glyoxal -1,1-dimethyl acetal, imidazole -1-yl acetonitrile, Indolo [2,3-A] carbazole, Methyl (3S)-7-bromo-2, 3-dihydro-2-oxo-5-(2-pyridyl)-1H-1, 4-benzodiazepine -3-propionate, Methylboronic acid, N-BOC-Amino-piperidinyl -1,1-carboxylic acid, N-Methyl morpholine borane, N-tert-butyl-1H-indazole-7-carboxamide, N,N-Diethylaniline Borane intermediates, N,N-dihexadecylphenylammonium tetrakis (pentafluorophenyl) borateN,N-dihexadecylanilinium tetrakis(pentafluorophenyl)borate, N,N-Dimethylanilinium tetrakis (pentafluorophenyl) borate, N,N-dioctadecylmethylammonium tetrakis(pentafluorophenyl)borate, Pinacolborane intermediates, Potassium tetrakis (pentafluorophenyl) borate, Propylgallate Injection, Pyridine-2-sulfonyl fluoride, (R)-( )-1-Phenylethanol, (R)-3-(Methoxymethyl) pyrrolidine -1-carboxylic acid ((3S,7aS)-7a-hydroxymethyl-6-(methylene) tetrahydro1H-pyrrorizin-3-yl) methanol ester, (R)-Methyl Oxazaborolidine intermediates, (S)-(-)-1-Phenylethanol, (S)-(-)-1,2, 3,4-tetrahydro-1-naphthoic acid, (S)-2-Amino-5-methoxytetrahydronaphthalene (S)-mandelate, (S)-2-Chloro-1-(2,4-dichlorophenyl), (S)-2-Chloro-1-(2,4-dichlorophenyl) ethyl methanesulfonate, (S)-3-Amino -3-(4-chlorophenyl)-propionic acid, (S)-Methyl Oxazaborolidine intermediates, Sodium tetrakis (pentafluorophenyl) borate, tert-Butyl 1-oxo-6-azospiro [2.5] octane -6-carboxylate, tert-Butyl 2-((4R,6R)-6-(2-(4-fluorophenyl)-4-((4-(hydroxymethyl) phenyl) carbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-2,2-dimethyl-1,3-diox-4-yl) acetate, tert-Butyl 3,3-dimethyl -4-(((trifluoromethyl) sulfonyl) oxy)-3,6-dihydropyridine -1(2H)-carboxylatetert-Butyl 3,3-dimethyl-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate, tert-Butyl (3S)-3-(4-bromophenyl) piperidine-1-carboxylatetert-butyl (S)-3-(4-bromophenyl)piperidine-1-carboxylate, tert-Butyl trans-(3R,4R)-3,4-diaminopyrrolidine-1-carboxylate, tert-Butyl trans-(3S,4S)-3,4-diaminopyrrolidine-1-carboxylate, Tetrabenzyl pyrophosphate, Triethylboron -1,3-propanediamine, Triethylboron -1,6-hexanediamine, Trimethylboroxine, Triphenylcarbon tetrakis (pentafluorophenyl) borate
- ATC(解剖学-治疗学-化学)分类系统: Vildagliptin, Aceglutamide Injection
我们的产品与服务
Sell · Pharma Chemicals
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
评分
(0)
(0)
(0)
(0)
(0)
评论
筛选：
排序方式：
暂无评论。
留下您的评分和评论